Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,690,355
-
Total 13F shares
-
163,472,233
-
Share change
-
-8,226,913
-
Total reported value
-
$673,496,034
-
Put/Call ratio
-
0.08%
-
Price per share
-
$4.12
-
Number of holders
-
218
-
Value change
-
-$53,233,700
-
Number of buys
-
101
-
Number of sells
-
121
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) as of Q3 2024
As of 30 Sep 2024,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
163,472,233 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Sarissa Capital Management LP, Pacer Advisors, Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, ARMISTICE CAPITAL, LLC, LSV ASSET MANAGEMENT, BRAIDWELL LP, and MORGAN STANLEY.
This page lists
218
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.